NewsRx

Search our medical news database

Product Licensing

Transplant company provides CE mark trial update

Published in Medical Letter on the CDC and FDA, January 9th, 2005

Ventracor Limited (VCR) provided an update on the CE Mark Trial which is the final step in achieving product registration in Europe.

A full contingent of staff from Norway will be trained in Melbourne. Rikshospitalet is one of the largest transplant centers in Europe.

Enrollment will begin immediately once final approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) has been received.

Papworth Hospital, Cambridge, is a pioneer in the use of mechanical heart assist devices and recently celebrated the 10th anniversary of its left ventricular assist system program.

In order to support the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook